Pieter Van den Abbeele performed a PhD and Postdoc (between 2007-2013) in applied microbiology and biotechnology at Ghent University, focussing on the improvement of existing and development of novel in vitro gut models. Between 2013-2020, he worked as senior scientist (2013-2014), research director (2015-2018) and CSO (2019-2020) in a CRO that commercialized these in vitro gut models. In 2021, Pieter Van den Abbeele founded a novel biotech company called Cryptobiotix.